Agents that inhibit bacterial biofilm formation

Future Medicinal Chemistry

Volumn 7, Issue 5, 2015, Pages 647-671

  Rabin, Nira ^a   Zheng, Yue ^a   Opoku Temeng, Clement ^a   Du, Yixuan ^a   Bonsu, Eric ^b   Sintim, Herman O ^a  

^a University of Maryland   (United States)

^b BOWIE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AUROMOMYCIN; CATION; DEXTRO AMINO ACID; FATTY ACID; FURANONE DERIVATIVE; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; IONIC LIQUID; N ACYLHOMOSERINE LACTONE; NITRIC OXIDE; PHENOL DERIVATIVE; PLANT EXTRACT; POLYPEPTIDE ANTIBIOTIC AGENT; POLYSACCHARIDE; SULFIDE; TRIAZOLE DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT; MOLECULAR LIBRARY;

ANTIBACTERIAL ACTIVITY; BACILLUS SUBTILIS; BACTERIUM; BIOFILM; DISPERSION; HUMAN; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; SORANGIUM CELLULOSUM; SURFACE PROPERTY; ANIMAL; BACTERIAL INFECTIONS; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MOLECULAR LIBRARY; PHARMACOLOGY; PROCEDURES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BIOFILMS; DRUG DISCOVERY; HUMANS; MICROBIAL SENSITIVITY TESTS; SMALL MOLECULE LIBRARIES;

EID: 84929991385     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.15.7     Document Type: Review

References (157)

1. Rasmussen TB, Givskov M. Quorum-sensing inhibitors as anti-pathogenic drugs. Int. J. Med. Biol. 296(2-3), 149-161 (2006).
2. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2), 167-193 (2002).
3. Stewart PS, William Costerton J. Antibiotic resistance of bacteria in biofilms. Lancet 358(9276), 135-138 (2001).
4. Worthington RJ, Richards JJ, Melander C. Small molecule control of bacterial biofilms. Org. Biomol. Chem. 10(37), 7457-7474 (2012).
5. Worthington RJ, Richards JJ, Melander C. Non-microbicidal control of bacterial biofilms with small molecules. Anti- Infective Agents 12(1), 120-138 (2014).
6. Hentzer M, Riedel K, Rasmussen TB et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148(1), 87-102 (2002).
7. Bjarnsholt T, Jensen PO, Rasmussen TB et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 151(12), 3873-3880 (2005).
8. Hu J-F, Garo E, Goering MG et al. Bacterial biofilm inhibitors from Diospyros dendo. J. Nat. Prod. 69(1), 118-120 (2006).
9. Garo E, Eldridge GR, Goering MG et al. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin. Antimicrob. Agents Chemother. 51(5), 1813-1817 (2007).
10. Wu H, Lee B, Yang L et al. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation. FEMS Immunol. Med. Microbiol. 62(1), 49-56 (2011).
11. Lee JH, Cho MH, Lee J. 3-indolylacetonitrile decreases Escherichia coli O157:H7 biofilm formation and Pseudomonas aeruginosa virulence. Environ. Microbiol. 13(1), 62-73 (2011).
12. Huigens RW, Richards JJ, Parise G et al. Inhibition of Pseudomonas aeruginosa biofilm formation with bromoageliferin analogues. J. Am. Chem. Soc. 129(22), 6966-6967 (2007).
13. Richards JJ, Ballard TE, Melander C. Inhibition and dispersion of Pseudomonas aeruginosa biofilms with reverse amide 2-Aminoimidazole oroidin analogues. Org. Biomol. Chem. 6(8), 1356-1363 (2008).
14. Richards JJ, Ballard TE, Huigens RW, Melander C. Synthesis and screening of an oroidin library against Pseudomonas aeruginosa biofilms. ChemBioChem 9(8), 1267-1279 (2008).
15. Rogers SA, Melander C. Construction and screening of a 2-Aminoimidazole library identifies a small molecule capable of inhibiting and dispersing bacterial biofilms across order, class, and phylum. Angew. Chem. Int. Ed. Engl. 47(28), 5229-5231 (2008).
16. Ballard TE, Richards JJ, Aquino A, Reed CS, Melander C. Antibiofilm activity of a diverse oroidin library generated through reductive acylation. J. Org. Chem. 74(4), 1755-1758 (2009).
17. Reyes S, Huigens III RW, Su Z, Simon ML, Melander C. Synthesis and biological activity of 2-Aminoimidazole triazoles accessed by Suzuki-Miyaura cross-coupling. Org. Biomol. Chem. 9(8), 3041-3049 (2011).
18. Su Z, Peng L, Worthington RJ, Melander C. Evaluation of 4, 5-disubstituted-2-Aminoimidazole-triazole conjugates for antibiofilm/antibiotic resensitization activity against MRSA and Acinetobacter baumannii. ChemMedChem 6(12), 2243-2251 (2011).
19. Yeagley AA, Su Z, McCullough KD, Worthington RJ, Melander C. N-substituted 2-Aminoimidazole inhibitors of MRSA biofilm formation accessed through direct 1, 3-bis(tert-butoxycarbonyl)guanidine cyclization. Org. Biomol. Chem. 11(1), 130-137 (2013).
20. Furlani RE, Yeagley AA, Melander C. A flexible approach to 1, 4-di-substituted 2-Aminoimidazoles that inhibit and disperse biofilms and potentiate the effects of β-lactams against multi-drug resistant bacteria. Eur. J. Med. Chem. 62(0), 59-70 (2013).
21. Rogers SA, Whitehead DC, Mullikin T, Melander C. Synthesis and bacterial biofilm inhibition studies of ethyl N-(2-phenethyl) carbamate derivatives. Org. Biomol. Chem. 8(17), 3857-3859 (2010).
22. Rogers SA, Lindsey EA, Whitehead DC, Mullikin T, Melander C. Synthesis and biological evaluation of 2-Aminoimidazole/carbamate hybrid anti-biofilm and anti-microbial agents. Bioorg. Med. Chem. Lett. 21(4), 1257-1260 (2011).
23. Frei R, Breitbach AS, Blackwell HE. 2-Aminobenzimidazole derivatives strongly inhibit and disperse Pseudomonas aeruginosa biofilms. Angew. Chem. Int. Ed. Engl. 51(21), 5226-5229 (2012).
24. Lindsey EA, Brackett CM, Mullikin T, Alcaraz C, Melander C. The discovery of N-1 substituted 2-Aminobenzimidazoles as zinc-dependent S. aureus biofilm inhibitors. MedChemComm. 3(11), 1462-1465 (2012).
25. Sambanthamoorthy K, Gokhale AA, Lao W et al. Identification of a novel benzimidazole that inhibits bacterial biofilm formation in a broad-spectrum manner. Antimicrob. Agents Chemother. 55(9), 4369-4378 (2011).
26. Martino PD, Fursy R, Bret L, Sundararaju B, Phillips RS. Indole can act as an extracellular signal to regulate biofilm formation of Escherichia coli and other indole-producing bacteria. Can. J. Microbiol. 49(7), 443-449 (2003).
27. Lee JH, Lee J. Indole as an intercellular signal in microbial communities. FEMS Microbiol. Rev. 34(4), 426-444 (2010).
28. Bansal T, Englert D, Lee J, Hegde M, Wood TK, Jayaraman A. Differential effects of epinephrine, norepinephrine, and indole on Escherichia coli O157:H7 chemotaxis, colonization, and gene expression. Infect. Immun. 75(9), 4597-4607 (2007).
29. Domka J, Lee J, Wood TK. YliH (BssR) and YceP (BssS) regulate Escherichia coli K-12 biofilm formation by influencing cell signaling. Appl. Environ. Microbiol. 72(4), 2449-2459 (2006).
30. Rui L, Reardon KF, Wood TK. Protein engineering of toluene ortho-monooxygenase of Burkholderia cepacia G4 for regiospecific hydroxylation of indole to form various indigoid compounds. Appl. Microbiol. Biotechnol. 66(4), 422-429 (2005).
31. Lee J, Bansal T, Jayaraman A, Bentley WE, Wood TK. Enterohemorrhagic Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin. Appl. Environ. Microbiol. 73(13), 4100-4109 (2007).
32. Lee JH, Kim YG, Kim CJ, Lee JC, Cho MH, Lee J. Indole- 3-Acetaldehyde from Rhodococcus sp. BFI 332 inhibits Escherichia coli O157:H7 biofilm formation. Appl. Microbiol. Biotechnol. 96(4), 1071-1078 (2012).
33. Bunders C, Cavanagh J, Melander C. Flustramine inspired synthesis and biological evaluation of pyrroloindoline triazole amides as novel inhibitors of bacterial biofilms. Org. Biomol. Chem. 9(15), 5476-5481 (2011).
34. Minvielle MJ, Bunders CA, Melander C. Indole/triazole conjugates are selective inhibitors and inducers of bacterial biofilms. MedChemComm 4(6), 916-919 (2013).
35. Ding X, Yin B, Qian L et al. Screening for novel quorumsensing inhibitors to interfere with the formation of Pseudomonas aeruginosa biofilm. J. Med. Microbiol. 60(12), 1827-1834 (2011).
36. Lee J-H, Regmi SC, Kim J-A et al. Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect. Immun. 79(12), 4819-4827 (2011).
37. Kolter R, Greenberg EP. Microbial sciences: the superficial life of microbes. Nature 441(7091), 300-302 (2006).
38. Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3(9), 541-548 (2007).
39. Kim H-S, Park H-D. Ginger extract inhibits biofilm formation by Pseudomonas aeruginosa PA14. PLoS One 8(9), e76106 (2013).
40. Schiavone BIP, Rosato A, Marilena M et al. Biological evaluation of hyperforin and its hydrogenated analogue on bacterial growth and biofilm production. J. Nat. Prod. 76(9), 1819-1823 (2013).
41. Sarkisian SA, Janssen MJ, Matta H, Henry GE, LaPlante KL, Rowley DC. Inhibition of bacterial growth and biofilm production by constituents from Hypericum spp. Phytother. Res. 26(7), 1012-1016 (2012).
42. Murata RM, Branco-de-Almeida LS, Franco EM et al. Inhibition of Streptococcus mutans biofilm accumulation and development of dental caries in vivo by 7-epiclusianone and fluoride. Biofouling 26(7), 865-872 (2010).
43. Vikram A, Jesudhasan PR, Jayaprakasha GK, Pillai SD, Patil BS. Citrus limonoids interfere with Vibrio harveyi cell-cell signalling and biofilm formation by modulating the response regulator LuxO. Microbiology 157(1), 99-110 (2011).
44. Vikram A, Jesudhasan P, Pillai S, Patil B. Isolimonic acid interferes with Escherichia coli O157:H7 biofilm and TTSS in QseBC and QseA dependent fashion. BMC Microbiol. 12(1), 261 (2012).
45. Artini M, Papa R, Barbato G et al. Bacterial biofilm formation inhibitory activity revealed for plant derived natural compounds. Biorg. Med. Chem. 20(2), 920-926 (2012).
46. Flamini G, Catalano S, Caponi C, Panizzi L, Morelli I. Three anthrones from Rubusulmifolius. Phytochemistry 59(8), 873-876 (2002).
47. Panizzi L, Caponi C, Catalano S, Cioni PL, Morelli I. In vitro antimicrobial activity of extracts and isolated constituents of Rubus ulmifolius. J. Ethnopharmacol. 79(2), 165-168 (2002).
48. Quave CL, Estévez-Carmona M, Compadre CM et al. Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics. PLoS One 7(1), e28737 (2012).
49. Payne DE, Martin NR, Parzych KR, Rickard AH, Underwood A, Boles BR. Tannic acid inhibits Staphylococcus aureus surface colonization in an isaa-dependent manner. Infect. Immun. 81(2), 496-504 (2013).
50. Lee J-H, Kim Y-G, Ryu SY, Cho MH, Lee J. Ginkgolic acids and Ginkgo biloba extract inhibit Escherichia coli O157:H7 and Staphylococcus aureus biofilm formation. Int. J. Food Microbiol. 174(0), 47-55 (2014).
51. Wu X-Y, Yang L-Q, Chen J, Yuan X-H, Xia G-H. Preparation of ginkgolic acid monomers and their antifungal activity. Chem. Industry Forest Products 23(4), 17-21 (2003).
52. He J, Wang S, Wu T, Cao Y, Xu X, Zhou X. Effects of ginkgoneolic acid on the growth, acidogenicity, adherence, and biofilm of Streptococcus mutans in vitro. Folia Microbiol. 58(2), 147-153 (2013).
53. Inamuco J, Veenendaal AKJ, Burt SA et al. Sub-lethal levels of carvacrol reduce Salmonella typhimurium motility and invasion of porcine epithelial cells. Vet. Microbiol. 157(1-2), 200-207 (2012).
54. Nostro A, Roccaro AS, Bisignano G et al. Effects of oregano, carvacrol and thymol on Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Med. Microbiol. 56(4), 519-523 (2007).
55. Soni KA, Oladunjoye A, Nannapaneni R et al. Inhibition and inactivation of Salmonella typhimurium biofilms from polystyrene and stainless steel surfaces by essential oils and phenolic constituent carvacrol. J. Food Prot. 76(2), 205-212 (2013).
56. Nostro A, Marino A, Blanco AR et al. In vitro activity of carvacrol against Staphylococcal preformed biofilm by liquid and vapour contact. J. Med. Microbiol. 58(6), 791-797 (2009).
57. Burt SA, Ojo-Fakunle VTA, Woertman J, Veldhuizen EJA. The natural antimicrobial carvacrol inhibits quorum sensing in Chromobacterium violaceum and reduces bacterial biofilm formation at sub-lethal concentrations. PLoS One 9(4), e93414 (2014).
58. Benamar M, Melhaoui A, Zyad A, Bouabdallah I, Aziz M. Anti-cancer effect of two alkaloids: 2R and 2S-bgugaine on mastocytoma P815 and carcinoma Hep. Nat. Prod. Res. 23(7), 659-664 (2009).
59. Majik MS, Naik D, Bhat C, Tilve S, Tilvi S, DSouza L. Synthesis of (R)-norbgugaine and its potential as quorum sensing inhibitor against Pseudomonas aeruginosa. Bioorg. Med. Chem. Lett. 23(8), 2353-2356 (2013).
60. Carneiro VA, Santos HS, Arruda FV et al. Casbane diterpene as a promising natural antimicrobial agent against biofilmassociated infections. Molecules 16(1), 190-201 (2011).
61. Lee J-H, Cho HS, Joo SW et al. Diverse plant extracts and trans-resveratrol inhibit biofilm formation and swarming of Escherichia coli O157:H7. Biofouling 29(10), 1189-1203 (2013).
62. Jang M, Cai L, Udeani GO et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275(5297), 218-220 (1997).
63. Cottart C-H, Nivet-Antoine V, Laguillier-Morizot C, Beaudeux J-L. Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food Res. 54(1), 7-16 (2010).
64. Li L, Henry GE, Seeram NP. Identification and bioactivities of resveratrol oligomers and flavonoids from Carex folliculata seeds. J. Agric. Food. Chem. 57(16), 7282-7287 (2009).
65. González-Sarrías A, Gromek S, Niesen D, Seeram NP, Henry GE. Resveratrol oligomers isolated from Carex species inhibit growth of human colon tumorigenic cells mediated by cell cycle arrest. J. Agric. Food. Chem. 59(16), 8632-8638 (2011).
66. Piver B, Berthou F, Dreano Y, Lucas D. Differential inhibition of human cytochrome P450 enzymes by ε-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages. Life Sci. 73(9), 1199-1213 (2003).
67. Cho HS, Lee J-H, Ryu SY, Joo SW, Cho MH, Lee J. Inhibition of Pseudomonas aeruginosa and Escherichia coli O157:H7 biofilm formation by plant metabolite ε-viniferin. J. Agric. Food. Chem. 61(29), 7120-7126 (2013).
68. Lee J-H, Kim Y-G, Ryu SY, Cho MH, Lee J. Resveratrol oligomers inhibit biofilm formation of Escherichia coli O157:H7 and Pseudomonas aeruginosa. J. Nat. Prod. 77(1), 168-172 (2014).
69. Persson T, Hansen TH, Rasmussen TB, Skinderso ME, Givskov M, Nielsen J. Rational design and synthesis of new quorum-sensing inhibitors derived from acylated homoserine lactones and natural products from garlic. Org. Biomol. Chem. 3(2), 253-262 (2005).
70. Jakobsen TH, van Gennip M, Phipps RK et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob. Agents Chemother. 56(5), 2314-2325 (2012).
71. Cady NC, McKean KA, Behnke J et al. Inhibition of biofilm formation, quorum sensing and infection in Pseudomonas aeruginosa by natural products-inspired organosulfur compounds. PLoS One 7(6), e38492 (2012).
72. Peach KC, Cheng AT, Oliver AG, Yildiz FH, Linington RG. Discovery and biological characterization of the auromomycin chromophore as an inhibitor of biofilm formation in Vibrio cholerae. ChemBioChem 14(16), 2209-2215 (2013).
73. Ren D, Bedzyk LA, Setlow P et al. Differential gene expression to investigate the effect of (5Z)-4-bromo- 5-(bromomethylene)-3-butyl-2(5H)-furanone on Bacillus subtilis. Appl. Environ. Microbiol. 70(8), 4941-4949 (2004).
74. Manefield M, de Nys R, Naresh K et al. Evidence that halogenated furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-mediated gene expression by displacing the AHL signal from its receptor protein. Microbiology 145(2), 283-291 (1999).
75. Manefield M, Rasmussen TB, Henzter M et al. Halogenated furanones inhibit quorum sensing through accelerated LuxR turnover. Microbiology 148(4), 1119-1127 (2002).
76. Ren D, Sims JJ, Wood TK. Inhibition of biofilm formation and swarming of Bacillus subtilis by (5Z)-4-bromo-5- (bromomethylene)-3-butyl-2(5H)-furanone. Lett. Appl. Microbiol. 34(4), 293-299 (2002).
77. Jayaraman A, Wood TK. Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. Annu. Rev. Biomed. Eng. 10(1), 145-167 (2008).
78. Benneche T, Herstad G, Rosenberg M, Assev S, Scheie AA. Facile synthesis of 5-(alkylidene)thiophen-2(5H)-ones. A new class of antimicrobial agents. RSC Advances 1(2), 323-332 (2011).
79. Yang S, Abdel-Razek OA, Cheng F et al. Bicyclic brominated furanones: a new class of quorum sensing modulators that inhibit bacterial biofilm formation. Biorg. Med. Chem. 22(4), 1313-1317 (2014).
80. Pereira UA, Barbosa LC, Maltha CR, Demuner AJ, Masood MA, Pimenta AL. γ-Alkylidene-γ-lactones and isobutylpyrrol-2(5H)-ones analogues to rubrolides as inhibitors of biofilm formation by Gram-positive and Gram-negative bacteria. Bioorg. Med. Chem. Lett. 24(4), 1052-1056 (2014).
81. Barreca ML, Chimirri A, De Luca L et al. Discovery of 2, 3-diaryl-1, 3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg. Med. Chem. Lett. 11(13), 1793-1796 (2001).
82. Goel B, Ram T, Tyagi R et al. 2-Substituted-3-(4-bromo- 2-carboxyphenyl)-5-methyl-4-thiazolidinones as potential anti-inflammatory agents. Eur. J. Med. Chem. 34(3), 265-269 (1999).
83. Allen S, Newhouse B, Anderson AS et al. Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists. Bioorg. Med. Chem. Lett. 14(7), 1619-1624 (2004).
84. Rane RA, Sahu NU, Shah CP. Synthesis and antibiofilm activity of marine natural product-based 4-thiazolidinones derivatives. Bioorg. Med. Chem. Lett. 22(23), 7131-7134 (2012).
85. de Lima Procoacute;pio RE, Silva IR, Martins MK, Azevedo JL, Araújo JM. Antibiotics produced by Streptomyces. Braz. J. Infect. Dis. 16(5), 466-471 (2012).
86. Navarro G, Cheng AT, Peach KC et al. Image-based 384- well high-throughput screening method for the discovery of skyllamycins a to c as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 58(2), 1092-1099 (2014).
87. Hertiani T, Edrada-Ebel R, Ortlepp S et al. From antifouling to biofilm inhibition: new cytotoxic secondary metabolites from two Indonesian Agelas sponges. Biorg. Med. Chem. 18(3), 1297-1311 (2010).
88. Tello E, Castellanos L, Arevalo-Ferro C, Rodríguez J, Jiménez C, Duque C. Absolute stereochemistry of antifouling cembranoid epimers at C-8 from the Caribbean octocoral Pseudoplexaura flagellosa: revised structures of plexaurolones. Tetrahedron 67(47), 9112-9121 (2011).
89. Amara N, Mashiach R, Amar D et al. Covalent inhibition of bacterial quorum sensing. J. Am. Chem. Soc. 131(30), 10610-10619 (2009).
90. Geske GD, Wezeman RJ, Siegel AP, Blackwell HE. Small molecule inhibitors of bacterial quorum sensing and biofilm formation. J. Am. Chem. Soc. 127(37), 12762-12763 (2005).
91. Geske GD, ONeill JC, Miller DM, Mattmann ME, Blackwell HE. Modulation of bacterial quorum sensing with synthetic ligands: systematic evaluation of N-Acylated homoserine lactones in multiple species and new insights into their mechanisms of action. J. Am. Chem. Soc. 129(44), 13613-13625 (2007).
92. Smith KM, Bu Y, Suga H. Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoinducer analogs. Chem. Biol. 10(1), 81-89 (2003).
93. Smith KM, Bu Y, Suga H. Library screening for synthetic agonists and antagonists of a Pseudomonas aeruginosa autoinducer. Chem. Biol. 10(6), 563-571 (2003).
94. Glansdorp FG, Thomas GL, Lee JK et al. Synthesis and stability of small molecule probes for Pseudomonas aeruginosa quorum sensing modulation. Org. Biomol. Chem. 2(22), 3329-3336 (2004).
95. Ishida T, Ikeda T, Takiguchi N, Kuroda A, Ohtake H, Kato J. Inhibition of quorum sensing in Pseudomonas aeruginosa by N-Acyl cyclopentylamides. Appl. Environ. Microbiol. 73(10), 3183-3188 (2007).
96. OLoughlin CT, Miller LC, Siryaporn A, Drescher K, Semmelhack MF, Bassler BL. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc. Natl Acad. Sci. USA 110(44), 17981-17986 (2013).
97. Yang Y-X, Xu Z-H, Zhang Y-Q, Tian J, Weng L-X, Wang L-H. A new quorum-sensing inhibitor attenuates virulence and decreases antibiotic resistance in Pseudomonas aeruginosa. J. Microbiol. 50(6), 987-993 (2012).
98. Weng L-X, Yang Y-X, Zhang Y-Q, Wang L-H. A new synthetic ligand that activates QscR and blocks antibiotictolerant biofilm formation in Pseudomonas aeruginosa. Appl. Microbiol. Biotechnol. 98(6), 2565-2572 (2014).
99. Brackman G, Risseeuw M, Celen S et al. Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones. Biorg. Med. Chem. 20(15), 4737-4743 (2012).
100. Asahi Y, Noiri Y, Igarashi J, Asai H, Suga H, Ebisu S. Effects of N-Acyl homoserine lactone analogues on Porphyromonas gingivalis biofilm formation. J. Periodontal Res. 45(2), 255-261 (2010).
101. Asahi Y, Noiri Y, Igarashi J, Suga H, Azakami H, Ebisu S. Synergistic effects of antibiotics and an N-Acyl homoserine lactone analog on Porphyromonas gingivalis biofilms. J. Appl. Microbiol. 112(2), 404-411 (2012).
102. Kunze B, Reck M, Dotsch A et al. Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum. BMC Microbiol. 10(1), 199 (2010).
103. Jansen R, Irschik H, Huch V et al. Carolacton: a macrolide ketocarbonic acid that reduces biofilm formation by the caries- and endocarditis-Associated bacterium Streptococcus mutans. Eur. J. Org. Chem. 2010(7), 1284-1289 (2010).
104. Hallside MS, Brzozowski RS, Wuest WM, Phillips AJ. A concise synthesis of carolacton. Org. Lett. 16(4), 1148-1151 (2014).
105. Blanco LP, Evans ML, Smith DR, Badtke MP, Chapman MR. Diversity, biogenesis and function of microbial amyloids. Trends Microbiol. 20(2), 66-73 (2012).
106. Maury CP. The emerging concept of functional amyloid. J. Intern. Med. 265(3), 329-334 (2009).
107. Schwartz K, Boles BR. Microbial amyloids: functions and interactions within the host. Curr. Opin. Microbiol. 16(1), 93-99 (2013).
108. Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus Biofilms. PLoS Pathog. 8(6), e1002744 (2012).
109. Vuong C, Saenz HL, Götz F, Otto M. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J. Infect. Dis. 182(6), 1688-1693 (2000).
110. Queck SY, Jameson-Lee M, Villaruz AE et al. RNAIIIindependent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell. 32(1), 150-158 (2008).
111. Mathema VB, Koh YS, Thakuri BC, Sillanp M. Parthenolide, a sesquiterpene lactone, expresses multiple anticancer and anti-inflammatory activities. Inflammation 35(2), 560-565 (2012).
112. Romero D, Sanabria-Valentin E, Vlamakis H, Kolter R. Biofilm inhibitors that target amyloid proteins. Chem. Biol. 20(1), 102-110 (2013).
113. Izadpanah A, Gallo RL. Antimicrobial peptides. J. Am. Acad. Dermatol. 52(3), 381-390 (2005).
114. de la Fuente-Núñez C, Korolik V, Bains M et al. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob. Agents Chemother. 56(5), 2696-2704 (2012).
115. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE. Human host defense peptide ll-37 prevents bacterial biofilm formation. Infect. Immun. 76(9), 4176-4182 (2008).
116. Johansson L, Thulin P, Sendi P et al. Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect. Immun. 76(8), 3399-3404 (2008).
117. Vuong C, Voyich JM, Fischer ER et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6(3), 269-275 (2004).
118. Hell E, Giske CG, Nelson A, Römling U, Marchini G. Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett. Appl. Microbiol. 50(2), 211-215 (2010).
119. Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R, Losick R. d-Amino acids trigger biofilm disassembly. Science 328(5978), 627-629 (2010).
120. Leiman SA, May JM, Lebar MD, Kahne D, Kolter R, Losick R. d-Amino acids indirectly inhibit biofilm formation in Bacillus subtilis by interfering with protein synthesis. J. Bacteriol. 195(23), 5391-5395 (2013).
121. Kolodkin-Gal I, Cao S, Chai L et al. A self-produced trigger for biofilm disassembly that targets exopolysaccharide. Cell 149(3), 684-692 (2012).
122. Hobley L, Kim Sok H, Maezato Y et al. Norspermidine is not a self-produced trigger for biofilm disassembly. Cell 156(4), 844-854 (2014).
123. Bendaoud M, Vinogradov E, Balashova NV, Kadouri DE, Kachlany SC, Kaplan JB. Broad-spectrum biofilm inhibition by Kingella kingae exopolysaccharide. J. Bacteriol. 193(15), 3879-3886 (2011).
124. Chai Y, Beauregard PB, Vlamakis H, Losick R, Kolter R. Galactose metabolism plays a crucial role in biofilm formation by Bacillus subtilis. mBio 3(4), e00184-12 (2012).
125. Holden HM, Rayment I, Thoden JB. Structure and function of enzymes of the leloir pathway for galactose metabolism. J. Biol. Chem. 278(45), 43885-43888 (2003).
126. Dusane DH, Rajput JK, Kumar AR, Nancharaiah YV, Venugopalan VP, Zinjarde SS. Disruption of fungal and bacterial biofilms by lauroyl glucose. Lett. Appl. Microbiol. 47(5), 374-379 (2008).
127. Dusane DH, Pawar VS, Nancharaiah YV, Venugopalan VP, Kumar AR, Zinjarde SS. Anti-biofilm potential of a glycolipid surfactant produced by a tropical marine strain of Serratia marcescens. Biofouling 27(6), 645-654 (2011).
128. Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl. Microbiol. Biotechnol. 85(6), 1629-1642 (2010).
129. Bergsson G, Arnfinnsson J, Karlsson SM, Steingrímsson O, Thormar H. In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother. 42(9), 2290-2294 (1998).
130. Bergsson G, Steingrímsson O, Thormar H. In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides. Antimicrob Agents Chemother. 43(11), 2790-2792 (1999).
131. Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother. 2(1), 23-28 (1972).
132. Feldlaufer M, Knox D, Lusby W, Shimanuki H. Antimicrobial activity of fatty-Acids against bacillus-larvae, the causative agent of American foulbrood disease. Apidologie 24(2), 95-99 (1993).
133. Wille JJ, Kydonieus A. Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against Gram-positive bacteria. Skin Pharmacol. Appl. Skin Physiol. 16(3), 176-187 (2003).
134. Georgel P, Crozat K, Lauth X et al. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with Gram-positive bacteria. Infect. Immun. 73(8), 4512-4521 (2005).
135. Stenz L, François P, Fischer A et al. Impact of oleic acid (cis-9-octadecenoic acid) on bacterial viability and biofilm production in Staphylococcus aureus. FEMS Microbiol. Lett. 287(2), 149-155 (2008).
136. Davies DG, Marques CN. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 191(5), 1393-1403 (2009).
137. Jennings JA, Courtney HS, Haggard WO. Cis-2-decenoic acid inhibits S. aureus growth and biofilm in vitro: a pilot study. Clin. Orthop. Relat. Res. 470(10), 2663-2670 (2012).
138. Roy V, Smith JA, Wang J, Stewart JE, Bentley WE, Sintim HO. Synthetic analogs tailor native AI-2 signaling across bacterial species. J. Am. Chem. Soc. 132(32), 11141-11150 (2010).
139. Smith JA, Wang J, Nguyen-Mau SM, Lee V, Sintim HO. Biological screening of a diverse set of AI-2 analogues in Vibrio harveyi suggests that receptors which are involved in synergistic agonism of AI-2 and analogues are promiscuous. Chem. Commun. (45), 7033-7035 (2009).
140. Gamby S, Roy V, Guo M et al. Altering the communication networks of multispecies microbial systems using a diverse toolbox of ai-2 analogues. ACS Chem. Biol. 7(6), 1023-1030 (2012).
141. Roy V, Meyer MT, Smith JA et al. AI-2 analogs and antibiotics: a synergistic approach to reduce bacterial biofilms. Appl. Microbiol. Biotechnol. 97(6), 2627-2638 (2013).
142. Barraud N, Hassett DJ, Hwang SH, Rice SA, Kjelleberg S, Webb JS. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 188(21), 7344-7353 (2006).
143. Barraud N, Schleheck D, Klebensberger J et al. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic digmp levels, and enhanced dispersal. J. Bacteriol. 191(23), 7333-7342 (2009).
144. Liu N, Xu Y, Hossain S et al. Nitric oxide regulation of cyclic di-gmp synthesis and hydrolysis in Shewanella woodyi. Biochemistry 51(10), 2087-2099 (2012).
145. Plate L, Marletta MA. Nitric oxide-sensing H-NOX proteins govern bacterial communal behavior. Trends Biochem. Sci. 38(11), 566-575 (2013).
146. Li Y, Heine S, Entian M, Sauer K, Frankenberg-Dinkel N. NO-induced biofilm dispersion in Pseudomonas aeruginosa is mediated by an MHYT domain-coupled phosphodiesterase. J. Bacteriol. 195(16), 3531-3542 (2013).
147. Gusarov I, Nudler E. NO-mediated cytoprotection: instant adaptation to oxidative stress in bacteria. Proc. Natl Acad. Sci. USA 102(39), 13855-13860 (2005).
148. Schreiber F, Beutler M, Enning D et al. The role of nitricoxide- synthase-derived nitric oxide in multicellular traits of Bacillus subtilis 3610: biofilm formation, swarming, and dispersal. BMC Microbiol. 11(1), 1-12 (2011).
149. Chung KK, Schumacher JF, Sampson EM, Burne RA, Antonelli PJ, Brennan AB. Impact of engineered surface microtopography on biofilm formation of Staphylococcus aureus. Biointerphases 2(2), 89-94 (2007).
150. Ma Y, Chen M, Jones JE, Ritts AC, Yu Q, Sun H. Inhibition of Staphylococcus epidermidis biofilm by trimethylsilane plasma coating. Antimicrob. Agents Chemother. 56(11), 5923-5937 (2012).
151. Treter J, Bonatto F, Krug C, Soares GV, Baumvol IJR, Macedo AJ. Washing-resistant surfactant coated surface is able to inhibit pathogenic bacteria adhesion. Appl. Surf. Sci. 303, 147-154 (2014).
152. Busetti A, Crawford DE, Earle MJ et al. Antimicrobial and antibiofilm activities of 1-Alkylquinolinium bromide ionic liquids. Green Chem. 12(3), 420-425 (2010).
153. Carson L, Chau PKW, Earle MJ et al. Antibiofilm activities of 1-Alkyl-3-methylimidazolium chloride ionic liquids. Green Chem. 11(4), 492-497 (2009).
154. Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. Biofilm formation mechanisms and targets for developing anti-biofilm agents. Future Med. Chem. 7(4), 493-512 (2015).
155. Abouelhassan Y, Garrison AT, Burch GM, Wong W, Norwood VM 4th, Huigens RW 3rd. Discovery of quinoline small molecules with potent dispersal activity against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a scaffold hopping strategy. Bioorg. Med. Chem. Lett. 24(21), 5076-5080 (2014).
156. Jennings MC, Ator LE, Paniak TJ, Minbiole KP, Wuest WM. Biofilm-eradicating properties of quaternary ammonium amphiphiles: simple mimics of antimicrobial peptides. Chembiochem.5(15), 2211-2215 (2014).
157. Garrison AT, Bai F, Abouelhassan Y, Paciaroni NG, Jin S, Huigens III RW. Bromophenazine derivatives with potent inhibition, dispersion and eradication activities against Staphylococcus aureus biofilms. RSC Adv. 5, 1120-1124 (2015).